B ERLIN -- After multiple failed attempts, an immune checkpoint inhibitor has broken through and landed a significant overall ...

In the current study, the association between mRNA COVID vaccination and survival was strongest among patients whose tumors ...

Invikafusp alfa demonstrated significant antitumor activity in TMB-H and MSI-H tumors resistant to immune checkpoint blockade, with ORRs ranging from 20.5% to 33.3%. The trial's safety profile was ...

A label expansion for Keytruda in platinum-resistant ovarian cancer would further entrench MSD’s dominance in the PD-1 space.

Camrelizumab and famitinib are projected to achieve global annual sales of $463 million and $108 million by 2031.

New research published in Cell finds the existence of craters on the surface of melanoma cells that serve as immune hubs, ...

Advanced colon cancer is the leading cause of cancer-related death in young American men and the second highest worldwide. In ...

(PFS) of 50% in the higher 15 mg/kg dose cohort compares favorably to historical PD-(L)1 refractory settings – All clinical responses, including a complete response, observed in the higher 15 mg/kg ...

Scientists have found that preserving lymph nodes during cancer surgery could dramatically improve how patients respond to ...

A landmark study headed by researchers at Yale School of Medicine and at Fred Hutchinson Cancer Center has revealed that autoantibodies (AAbs)—immune proteins traditionally associated with autoimmune ...